HTA - NIHR127900

Olaparib for maintenance treatment of BRCA-mutated ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [ID1124]

Project title: Olaparib for maintenance treatment of BRCA-mutated ovarian, fallopian tube and peritoneal cancer after response to first-line platinum-based chemotherapy [ID1124]

Call to action: 18/88 Batch 62

Research type: Evidence Synthesis

Chief investigator: Professor Matt Stevenson

Contractor: The University of Sheffield

Cost: £65,625.00

Started: January 2019 | Status: Project complete

Links to project documentation

The links and documents below are related to this research and are added as and when they are produced over the life of the project. The information is provided by the researchers and some may have undergone varying editorial, production and publication models, which differ to NIHR Journals Library reports. Links are to both internal (NIHR) and external websites – the NIHR is not responsible for the content of external websites.